Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells

World Journal of Surgery

Volumn 33, Issue 11, 2009, Pages 2452-2457

  Adler, Joel T ^a   Hottinger, Daniel G ^a   Kunnimalaiyaan, Muthusamy ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CHROMOGRANIN A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR MASH1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PHEOCHROMOCYTOMA; RAT; WESTERN BLOTTING;

ADRENAL GLAND NEOPLASMS; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; HUMANS; MORPHOLINES; PHEOCHROMOCYTOMA; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 70350033524     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0175-3     Document Type: Article

References (20)

1. JT Adler GY Meyer-Rochow H Chen, et al. 2008 Pheochromocytoma: current approaches and future directions Oncologist 13 779 793 18617683 10.1634/theoncologist.2008-0043
2. WM Manger 2005 The vagaries of pheochromocytomas Am J Hypertens 18 1266 1270 16202846 10.1016/j.amjhyper.2005.06.026 (Pubitemid 41400192)
3. Manger WM, Gifford JRW (1996) Clinical and experimental pheochromocytoma. Blackwell Science, Cambridge
4. PP Stein HR Black 1991 A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience Medicine (Baltimore) 70 46 66 1:STN:280:DyaK3M7gvFGltg%3D%3D
5. JT Adler E Mack H Chen 2007 Isolated adrenal mass in patients with a history of cancer: remember pheochromocytoma Ann Surg Oncol 14 2358 2362 17505857 10.1245/s10434-007-9426-4 (Pubitemid 47174923)
6. X Zhang B Jin C Huang 2007 The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention Curr Cancer Drug Targets 7 305 316 17979625 10.2174/156800907780809741 1:CAS:528:DC%2BD2sXmsV2msr8%3D (Pubitemid 46849235)
7. J Bussink AJ van der Kogel JH Kaanders 2008 Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer Lancet Oncol 9 288 296 18308254 10.1016/S1470-2045(08)70073-1 1:CAS:528:DC%2BD1cXivVaqtb0%3D (Pubitemid 351722948)
8. H Dudek SR Datta TF Franke, et al. 1997 Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 661 665 9005851 10.1126/science.275.5300.661 1:CAS:528:DyaK2sXptV2msA%3D%3D (Pubitemid 27061332)
9. R Yao GM Cooper 1995 Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor Science 267 2003 2006 7701324 10.1126/science.7701324 1:CAS:528:DyaK2MXkslOkur0%3D
10. M Alvarez-Tejado S Naranjo-Suarez C Jimenez, et al. 2001 Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis J Biol Chem 276 22368 22374 11294857 10.1074/jbc.M011688200 1:CAS:528:DC%2BD3MXkvVamsrw%3D
11. M Fassnacht D Weismann S Ebert, et al. 2005 AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors J Clin Endocrinol Metab 90 4366 4370 15855265 10.1210/jc.2004-2198 1:CAS:528:DC%2BD2MXmtlChs74%3D (Pubitemid 41058221)
12. RS Sippel JE Carpenter M Kunnimalaiyaan, et al. 2003 Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells Am J Physiol Gastrointest Liver Physiol 285 G245 G254 12851216 1:CAS:528:DC%2BD3sXmsVahtr0%3D
13. A Kappes A Vaccaro M Kunnimalaiyaan, et al. 2006 ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells J Surg Res 133 42 45 16603190 10.1016/j.jss.2006.02.002 1:CAS:528:DC%2BD28XksVahuro%3D
14. A Kappes A Vaccaro M Kunnimalaiyaan, et al. 2007 Lithium ions: a novel treatment for pheochromocytomas and paragangliomas Surgery 141 161 165 17263970 10.1016/j.surg.2006.12.005 (Pubitemid 46157252)
15. JT Adler DG Hottinger M Kunnimalaiyaan, et al. 2008 Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells Surgery 144 956 961 19041003 10.1016/j.surg.2008.08.027
16. M Kunnimalaiyaan M Ndiaye H Chen 2006 Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002 Surgery 140 1009 1014 17188151 10.1016/j.surg.2006.06.040 (Pubitemid 44940811)
17. RS Sippel JE Carpenter M Kunnimalaiyaan, et al. 2003 The role of human achaete-scute homolog-1 in medullary thyroid cancer cells Surgery 134 866 871 14668716 10.1016/S0039-6060(03)00418-5 (Pubitemid 38010730)
18. Y Dai Z Wei CF Sephton, et al. 2007 Haloperidol induces the nuclear translocation of phosphatidylinositol 3′-kinase to disrupt Akt phosphorylation in PC12 cells J Psychiatry Neurosci JPN 32 323 330
19. K Huber B Bruhl F Guillemot, et al. 2002 Development of chromaffin cells depends on MASH1 function Development 129 4729 4738 12361965 1:CAS:528:DC%2BD38XosF2jsrw%3D
20. JR Garlich P De N Dey, et al. 2008 A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity Cancer Res 68 206 215 18172313 10.1158/0008-5472.CAN-07- 0669 1:CAS:528:DC%2BD1cXoslSn